Home » CLINICAL DATA INITIATES PATIENT ENROLLMENT FOR VILAZODONE TRIAL
CLINICAL DATA INITIATES PATIENT ENROLLMENT FOR VILAZODONE TRIAL
Clinical Data has initiated patient enrollment in a pivotal Phase III clinical research study of vilazodone, a novel dual serotonergic antidepressant compound being studied for treatment of depression.
The company anticipates having initial results from this study available by mid-2007 and anticipates at least one long-term safety study and one additional pivotal study will be required prior to filing a new drug application.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May